~ icon. cancer care. TGA Submission: Options for reform of the regulatory framework for pharmacy compounding
|
|
- Gyles Antony Sparks
- 8 years ago
- Views:
Transcription
1 ~ icon cancer care TGA Submission: Options for reform of the regulatory framework for pharmacy compounding
2 Introduction Icon Cancer Care is pleased to have the opportunity to make this submission regarding reform options for Australia s regulatory framework for pharmacy compounding. Put simply, our mission is to provide exceptional, personalised care to cancer patients and their families. We currently manage more than 73,000 patient separations (visits) each year under three brands Haematology & Oncology Clinics of Australia (HOCA), Queensland Haematology & Oncology Group (QHOG) and Tennyson Infusion Centre (Adelaide) with the support of more than 70 visiting medical officers (VMOs). In addition to supporting the VMOs who refer to our day hospitals and other smaller private hospitals in regional Queensland, Icon Cancer Care directly employs more than 370 staff, including 24 pharmacists. Our HOCA operating brand has been leading the way in cancer care for 25 years and became the foundation for Integrated Clinical Oncology Network Pty Ltd (now trading as Icon Cancer Care), a privately owned company established in February It should be noted all of our operations will be transitioning to the Icon Cancer Care brand throughout August and September Table 1 provides a snapshot of our day hospital operation and chair capacity, including for our new day hospital in Townsville, north Queensland, which is currently under development to help meet the growing demands of that region. The table also details our pharmacy model of service per site. Table 1 Icon facilities and pharmacy services Icon site Chair numbers Pharmacy services Nature of compounding service Wesley 29 Clinical support on-site and at River City Pharmacy (QCPP licensed). Mater 27 Clinical support on-site and at River City Pharmacy (QCPP licensed). HOCA Chermside 25 Clinical support and compounding. Compounding of complex cytotoxic items as well as monoclonal anti-bodies. Pressurised class C ante- and clean room with class A isolators. Compounding of complex cytotoxic items as well as monoclonal anti-bodies. Pressurised class C ante- and clean room with class A isolators. Compounding of monoclonal antibodies only using a closed system and aseptic technique. HOCA Gold Coast 28 Clinical support. No compounding on-site. Third party TGA supplier only. Tennyson Infusion Centre Adelaide 27 Clinical support. No compounding on-site. Third party TGA supplier only. Icon Cancer Care Townsville 15 Clinical support and compounding. Compounding of monoclonal antibodies only using a closed system and a septic technique. 2
3 Icon aims to maintain an integrated operating model where doctors, treatment, pharmacy and research are co-located, creating greater efficiencies for patients and those who treat them. Our Icon Pharmacy Services model uses a third party TGA supplier for of our reconstituted chemotherapy and monoclonal antibody preparation. The other is compounded by our pharmacies and is purely extemporaneous compounding with no bulk preparation. Items that we compound have a short expiry, are for newly diagnosed patients needing to start their chemotherapy the same day and for dosage changes for patients waiting in the chair. Icon Pharmacy Services follows good manufacturing practice and the guidelines set by the Pharmaceutical Society of Australia s (PSA) Professional Practice Standards, Society of Hospital Pharmacists of Australia s (SHPA) Safe Handling of Chemotherapy and the International Society of Oncology Pharmacy Practitioners (ISOPP). We also conduct annual oncology and oncology manufacturing audits that are benchmarked externally with the APHS Group. We acknowledge that the scope of this consultation does not extend to the traditional role of the pharmacist in preparing medicine for a particular patient (page 6). However, we would like to submit our comments in line with our support for a form of professional regulation for pharmacies dispensing extemporaneous complex medication (this is cytotoxics for Icon Cancer Care s Pharmacies), put in place with the aim of guaranteeing patient safety. Icon Cancer Care is happy to share its view on reform options in the hope of avoiding significant risk to the continuity and cost of patient care. Icon Cancer Care thanks the Therapeutics Good Administration for its consideration of the following information. Responses to questions in consultation paper Option A status quo Are there other risks and benefits of the continuation of existing regulatory arrangements that have not been identified in this consult paper? While there are currently extensive guidelines and practice standards that apply to compounding, there is no enforced regulation to accompany it and to guarantee that regular and sufficient environmental monitoring is applied, or that good manufacturing practices are followed in the case of complex compounding of medicine with option A. This poses a potential risk to not only the safety of patients for whom the medication is compounded, but also for operators in the case of manufacturing cytotoxics. Icon Cancer Care does not support option A. 3
4 Option B enhance co-regulation and update legislation Do you have any views on how option B could be approved? Icon Cancer Care supports the view that a National Pharmacy Compounding audit should be implemented by an appropriate regulatory body other than the TGA. This could be done in collaboration with the TGA, but it should be clearly distinguished from the TGA approval process. What wording should be used on medicine labels to highlight that the medicine is compounded? Icon Cancer Care suggests that the words This is a compounded medicine should be used on medicine labels to highlight that medicine is compounded. Icon Cancer Care supports option B. Option C manufacturing licence for specified manufacture in pharmacies What are the risks and benefits of option C? Icon Cancer Care believes option C will pose significant risk to the continuity and cost of patient care. Good manufacturing processes are currently followed at our compounding pharmacy River City Pharmacy which already results in an average turnaround time of an hour and a half from when a medicine order is received to delivery of it to one of our day hospitals. The convoluted process of working within a TGA registered facility would significantly slow down provision of chemotherapy to patients (extemporaneously compounded products), leading to increased wait times and poor patient service. The process of having pharmacies TGA approved, together with any required refurbishments to bring premises up to the specified standard, would add significant costs to patient care and would not be affordable to Icon Cancer Care and most other pharmacy operators. This poses a risk of additional costs being passed on to patients. If your business would be affected by this proposal, what would be the financial impact on your business and flow-on impact on consumers, if any? We recently looked at refurbishing two new pharmacies in each of our smaller Icon Cancer Care day hospitals to meet the current PICs. The estimated costs for each of these would have been almost $500,000. This amount does not consider any costs involved in having them TGA approved and any associated annual licensing fees. Additionally, staffing costs to maintain TGA processes would also dramatically increase due to the introduction of extra processes. Current TGA approved pharmacies and third party providers operate a business model independent of PBS funding. They structure the pricing of the compounded molecules in such a way that makes them commercially viable. On the other hand, private pharmacy providers are dependent upon reimbursement through the PBS. Pharmacy operators are currently negotiating with the Australian 4
5 Government to overcome the PBS funding shortfall for chemotherapy. The negotiations are based on the current costs of supply of services by chemotherapy compounding pharmacies. A move to make TGA accreditation compulsory for compounding pharmacies will mean yet another gap in the PBS funding for the supply of chemotherapy an unsustainable move for Icon Cancer Care. For consumers, the flow-on impact would be on the cost of their patient care. Icon Cancer Care does not support options C1, C2 or C3. In sub-option C3, which means of controlling quantity do you support? Icon Cancer Care does not support any controlling quantity where a pharmacy has to become TGA approved if it surpasses certain volumes of products compounded per month. We do not support the suggested controlling quantity of 500 compounded products per month. At the commencement of any new requirement for requiring a manufacturing licence, would a two year transition time to be sufficient? Icon Cancer Care suggests a transition time of up to three years would be sufficient. Option C3 will be too costly and is not supported. Conclusion In conclusion, Icon Cancer Care supports option B manufacturing licence for specified manufacture in pharmacies. Icon Cancer Care recommends that a similar process as to what is recommended in option B be regulated under the control of the Pharmacy Board as a central body with possible input from the TGA. Icon submits this submission provisionally, pending the Pharmacy Board of Australia discussion paper that is due to be released. 5
GUIDELINES ON COMPOUNDING OF MEDICINES. March 2015. PharmBA1502 01
GUIDELINES ON COMPOUNDING OF MEDICINES March 2015 PharmBA1502 01 Contents Who needs to use these guidelines?............................................. 3 Introduction..........................................................
More informationHospital pharmacy technician role / service definition grid
Hospital pharmacy technician role / service definition grid To be a competent hospital pharmacy technician, you must be able to complete the required task to the defined standard and to do this on every
More informationHIGHLY SPECIALISED DRUGS PROGRAM AND HERCEPTIN PROGRAM. Western Australia Administrative Guidelines
HIGHLY SPECIALISED DRUGS PROGRAM AND HERCEPTIN PROGRAM Western Australia Administrative Guidelines Pharmaceutical Services Branch Health Protection Group Table of Contents BACKGROUND...1 Overview...1 AHMAC
More informationDraft guidance for registered pharmacies preparing unlicensed medicines
Draft guidance for registered pharmacies preparing unlicensed medicines January 2014 1 The General Pharmaceutical Council is the regulator for pharmacists, pharmacy technicians and registered pharmacies
More informationPreparation and Handling of Cytotoxic, Hazardous and Potentially Hazardous Medicines Policy
Department of Health and Human Services SYSTEM PURCHASING AND PERFORMANCE - MEDICATION STRATEGY AND REFORM Preparation and Handling of Cytotoxic, Hazardous and Potentially Hazardous Medicines Policy SDMS
More informationAn introduction to the Pharmaceutical Benefits Scheme
An introduction to the Pharmaceutical Benefits Scheme Introduction The use of medicines is the most common health intervention to combat illness and disease and promote good health and wellness. Of the
More informationEducational Outcomes for Pharmacy Technician Programs in Canada
Canadian Pharmacy Technician Educators Association (CPTEA) Educational Outcomes for Pharmacy Technician Programs in Canada March 2007 Educational Outcomes for Pharmacy Technician Page 1 of 14 Framework
More informationEnsuring Best Practice in the Notification of Prescription Medical Product Discontinuations
Ensuring Best Practice in the Notification of Prescription Medical Product Discontinuations TGA and Medicines Australia Conjoint Best Practice Guidelines October 2007 1 Ensuring Best Practice in the Notification
More informationSaskTech (Guidance Document) An Evaluation and Monitoring Tool For Pharmacy Assistants
SaskTech (Guidance Document) An Evaluation and Monitoring Tool For Pharmacy Assistants September 2007 1 TABLE OF CONTENTS Page Introduction...3 Pharmacy Assistant/Technician Training Programs... 4 Pharmacy
More informationENDORSED BY THE GOVERNANCE COMMITTEE
Guideline for the Preparation or Manipulation of Monoclonal Antibodies (MABs) and related compounds such as Fusion Proteins, used in the Treatment of Cancer Date Approved by Network Governance July 2012
More informationChanging the shape of the Australian pharmacy industry
+ Changing the shape of the Australian pharmacy industry An API & Alphapharm partnership A five year strategic partnership: Brings together two of the pharmacy industry s leading brands Alphapharm is the
More informationBoard of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy. Disclosure. Objectives 9/9/2015
Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy Disclosure I have nothing to disclose and further, I was not paid an honorarium or travel reimbursement
More informationTable of Contents Service Information... 2
Protocol October 2015 Version 1.1 Table of Contents Service Information... 2 Service objective... 2 Clinical service overview... 2 Documentation... 2 Staff Roles... 3 Facilities to support the program...
More informationGuidelines for dispensing of medicines 6585 08/10
for dispensing of medicines 6585 08/10 for dispensing of medicines Contents Introduction 1 Who needs to use these guidelines? 1 Summary of guidelines 1 1 1 Dispensing precaution safety of prescriptions
More informationImproving Access for Indigenous Australians to Medicare and the Pharmaceutical Benefits Scheme
Improving Access for Indigenous Australians to Medicare and the Pharmaceutical Benefits Scheme Geoff Gillett 5th National Rural Health Conference Adelaide, South Australia, 14-17th March 1999 Proceedings
More informationPHARMACY TECHNICIAN SERIES
PHARMACY TECHNICIAN SERIES Occ. Work Prob. Effective Last Code No. Class Title Area Area Period Date Action 4058 Pharmacy Technician I 12 446 6 mo. 02/15/04 Revised 4059 Pharmacy Technician II 12 446 6
More informationSUBMISSION TO THE SENATE INQUIRY INTO OUT-OF- POCKET COSTS IN AUSTRALIAN HEALTHCARE. Prepared by National Policy Office
SUBMISSION TO THE SENATE INQUIRY INTO OUT-OF- POCKET COSTS IN AUSTRALIAN HEALTHCARE Prepared by National Policy Office May 2014 COTA Australia Authorised by: Ian Yates AM Chief Executive iyates@cota.org.au
More informationFor us, cancer is personal. From Diagnosis: Taking the next step
For us, cancer is personal From Diagnosis: Taking the next step Contents Introduction.... 2 About Icon Cancer Care.... 3 The next step, and beyond.... 4 What can I expect at my next visit?... 4 What should
More informationFreedom of Information Act Request Reference FoI/13/051 Pre-registration Trainee Pharmacy Technicians
Freedom of Information Act Request Reference FoI/13/051 Pre-registration Trainee Pharmacy Technicians Request details: Can you please provide me with the following information: Question 1 - Total no of
More informationGUIDANCE ON THE SAFE HANDLING OF MONOCLONAL ANTIBODY (mab) PRODUCTS
GUIDANCE ON THE SAFE HANDLING OF MONOCLONAL ANTIBODY (mab) PRODUCTS 5 th Edition November 2015 NHS Pharmaceutical Quality Assurance Committee 2015 British Oncology Pharmacists Association Pharmaceutical
More informationLicensed Pharmacy Technician Scope of Practice
Licensed Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 Definitions In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated
More informationPrivate Health Improvements.
Private Health Improvements. Australia s health system is one of the best in the world a unique mix of public and private health care designed to make sure all Australians are well covered for their needs.
More informationCHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS
CHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS Overview 6.1 This chapter sets out the Review Committee s findings and recommendations on procurement
More informationBaseline Assessments Reveal Opportunities for Hospital Pharmacies
Baseline Assessments Reveal Opportunities for Hospital Pharmacies Key findings around policies and procedures, traceability, compounding and professional responsibilities By Stuart Foxman PAGE 8 ~ WINTER
More informationMedication Management Guidelines for Nurses and Midwives
Medication Management Guidelines for Nurses and Midwives 1. Introduction As the statutory body responsible for the regulation of nursing and midwifery practice in Western Australia (WA), the Nurses & Midwives
More informationHealth Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents
Health Professions Act BYLAWS SCHEDULE F PART 3 Residential Care Facilities and Homes Standards of Practice Table of Contents 1. Application 2. Definitions 3. Supervision of Pharmacy Services in a Facility
More informationNATIONAL PROFILES FOR PHARMACY CONTENTS
NATIONAL PROFILES FOR PHARMACY CONTENTS Profile Title AfC Banding Page Pharmacy Support Worker 2 2 Pharmacy Support Worker Higher Level Pharmacy Technician 4 4 Pharmacy Technician Higher Level (Pharmacy
More informationRegistration standard: Endorsement as a nurse practitioner
Registration standard: Endorsement as a nurse practitioner Consultation report February 2016 Nursing and Midwifery Board of Australia G.P.O. Box 9958 Melbourne VIC 3001 www.nursingmidwiferyboard.gov.au
More informationPosition Statement: Safe handling of monoclonal antibodies in healthcare settings
Position Statement: Safe handling of monoclonal antibodies in healthcare settings Introduction Monoclonal antibodies (MABs) were introduced into clinical practice in the mid 1980s, with their use in the
More informationPharmacy Policy (General)
WORKSAFE VICTORIA Pharmacy Policy (General) WorkSafe can pay the reasonable costs of medications and other pharmacy items required as a result of a work-related injury or illness in accordance with Victorian
More informationCommunity Pharmacy Roadmap Program Development Template
Community Pharmacy Roadmap Program Development Template Program/Service: Quadrant: Pharmacist Only Medicine Notifiable (POMN) B- Pharmacy medicines and health products services and programs 1. Program/Service
More informationBarton Deakin: Commission of Audit Report Health. 7 May 2014
Barton Deakin: Commission of Audit Report Health 7 May 2014 The Report delivered to the Government by the National Commission of Audit contained several recommendations to reform the Australian health
More informationTherapeutic Goods Administration Orphan Drugs Program: Discussion paper
Therapeutic Goods Administration Orphan Drugs Program: Discussion paper Submission from the Clinical Oncology Society of Australia and Cancer Council Australia March 2015 The Clinical Oncology Society
More informationUse of the Coat of Arms The terms under which the Coat of Arms can be used are set out on the It s an Honour website (see www.itsanhonour.gov.
Health 13 May 2014 Commonwealth of Australia 2014 ISBN 978-0-642-74982-6 This publication is available for your use under a Creative Commons Attribution 3.0 Australia licence, with the exception of the
More informationVersion 1.0 November 2013 Developed by: Working group of the HPAI Aseptic Services Special Interest Group (ASSIG)
(H-PIC\S) Version 1.0 November 2013 Developed by: Working group of the HPAI Aseptic Services Special Interest Group (ASSIG) The working group of the HPAI ASSIG was chaired by: Aisling Collins BSc (Pharm),
More information11 MEDICATION MANAGEMENT
1 11 MEDICATION MANAGEMENT OVERVIEW OF MEDICATION MANAGEMENT Depending on the size, structure and functions of the health facility, there may be a pharmacy with qualified pharmacists to dispense medication,
More informationImproving advertising arrangements for therapeutic goods
Comments on the Consultation Paper Improving advertising arrangements for therapeutic goods 27 August 2010 Background (Guild) is pleased to be able to provide comment to the Therapeutic Goods Administration
More informationHow To Be A Senior Pharmacy Technician
JOB DESCRIPTION JOB TITLE : Senior Pharmacy Technician DEPARTMENT : Pharmacy Heartlands, Solihull & Good Hope Hospitals GRADE : Band 5 HOURS OF DUTY : 37.5 hours per week. The Trust operates a 7 day working
More information5/5/2015 PHARMACY WHAT S AN EMPLOYER TO DO? Current Structure Misaligned
PHARMACY WHAT S AN EMPLOYER TO DO? MAY 15, 2015 Debbie Doolittle Nashville, TN Pharmaceutical Spending Per Capita, 2013 vs. 2018 The US vs. the Rest of the World 1 Current Pharmacy Landscape How Did We
More informationSubmission to the Senate inquiry into out-of-pocket costs in Australian healthcare
MULTIPLE SCLEROSIS AUSTRALIA Submission to the Senate inquiry into out-of-pocket costs in Australian healthcare 15 May 2014 Debra Cerasa Chief Executive Officer Multiple Sclerosis Australia ABN 51 008
More informationAT RSM, WE KNOW PHARMACY. PHARMACY SERVICES. Your strategic partner, focused on pharmacy.
AT RSM, WE KNOW PHARMACY. PHARMACY SERVICES Your strategic partner, focused on pharmacy. EXPERIENCE THE POWER OF BEING UNDERSTOOD At RSM, we know pharmacy. First-hand knowledge 20 years of Pharmacy experience
More informationClinical Intervention Definitions
Pharmacy Practice Incentive (PPI) Program Clinical Intervention Definitions $97 million over the life of the Agreement (5 years) Clinical Intervention - Definitions A clinical intervention: is a professional
More informationCancer Diagnosis Support
For us, cancer is personal From Diagnosis: Taking the next step Contents Introduction.... 2 About Icon Cancer Care.... 3 The next step, and beyond.... 4 What can I expect at my next visit?... 4 What should
More informationField Report Field Report Field Report Field Report Field Report
Starting a Pharmaceutical Program Program for Pharmaceutical Care A report written by organizers of volunteerbased health care programs serving the uninsured. 1 to Underserved PHARMACEUTICAL Starting a
More informationSTRATEGIC OUTLINE CASE PHARMACY STOCK CONTROL PROJECT DOCUMENTATION. Release: Draft vs. 0.5. Date: 6th June 2008
PROJECT DOCUMENTATION STRATEGIC OUTLINE CASE PHARMACY STOCK CONTROL Release: Draft vs. 0.5 Date: 6th June 2008 Author: Liz Boylan Noy Scott House RDEH(Wonford) Barrack Road Exeter EX2 5DW Tel: 01392 402365
More informationHOSPITAL PHARMACY PRACTICE IN THE UK AND THE RESPONSIBLE PHARMACIST REQUIREMENTS
HOSPITAL PHARMACY PRACTICE IN THE UK AND THE RESPONSIBLE PHARMACIST REQUIREMENTS ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN AND THE PHARMACEUTICAL SOCIETY OF NORTHERN IRELAND STATUS OF THIS DOCUMENT
More informationAUSTRALIAN PACKAGING COVENANT
AUSTRALIAN PACKAGING COVENANT ACTION PLAN APRIL 2012 to MARCH 2015 1 P a g e Table of Contents Executive Summary 3 Endorsement 3 Company Overview 3 Locations 3 Our Brands 4 Integria Healthcare Packaging
More informationQUM and Continuity of Care A Prescribed Medicines Services and Programs
Community Pharmacy Roadmap Program Development Template Program/Service: Quadrant: 1. Program/Service Description QUM and Continuity of Care A Prescribed Medicines Services and Programs a) Background The
More informationJob Description. Pharmacy Technician - Pharmacy Services Tauranga Hospital
Job Description Pharmacy Technician - Pharmacy Services Tauranga Hospital Report To: Liaise with: Senior Pharmacy Technician Pharmacy Manager Pharmacists, Pharmacy Technicians, Intern Pharmacists and other
More informationGuidance on the content of a pharmacy manual to support clinical trial protocols
Guidance on the content of a pharmacy manual to support clinical trial protocols This guidance has been produced to help investigators with the content of pharmacy manuals for clinical trials. We gratefully
More informationPART 14 CORE BUSINESS RULES FOR REIMBURSEMENT SCOTTISH DRUG TARIFF PART 14 CORE BUSINESS RULES FOR REIMBURSEMENT
SCOTTISH DRUG TARIFF PART 14 PREFACE The rules as set out below are the basic requirement for reimbursement of items presented on NHS primary care prescription in Scotland. These rules cover both printed
More informationLawyers for Health Team
Lawyers for Health Lawyers for Health Team Mary Edquist Senior Consultant White & Mason Lawyers Tel: +61 3 9088 0486 Fax: +61 3 9621 3389 Email: mle@whiteandmason.com.au Mary has extensive experience in
More informationUNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,
More informationNational Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment
NPSA Injectable Medicines Risk Assessment Tool National Patient Safety Agency Risk Assessment of Injectable Medicines STEP 1 Local Risk Factor Assessment. Carry out a baseline assessment in a near patient
More informationThe regulation of pharmacy ownership in Australia: The potential impact of changes to the health landscape
The regulation of pharmacy ownership in Australia: The potential impact of changes to the health landscape H Laetitia Hattingh * Australian community pharmacy ownership restrictions have been in place
More informationFormulary notes for the List of Approved Medicines
Formulary notes for the List of Approved Medicines Last updated May 2016 Contents Introduction... 2 Formulary notes... 2 Generic listing of medicines... 2 PBS items... 2 Restrictions... 3 Applications
More informationHelping pharmaceutical, life science and other healthcare companies respond to a changing environment
Helping pharmaceutical, life science and other healthcare companies respond to a changing environment Real and immediate challenges Life sciences, pharmaceutics and health care are experiencing a period
More informationCourse Viability Policy - Higher Education ACA-022
Course Viability Policy Higher Education Policy Code: ACA-022 Version: 3.0 Effective Date: 2 July 2015 Purpose: This policy is necessary in order to ensure the economic viability of all accredited higher
More informationRegulatory Reform: Are we heading in the right direction?
Regulatory Reform: Are we heading in the right direction? Trisha Garrett, Assistant Secretary, Complementary and OTC Medicines Branch 11 November 2015 Where are we going? 2 Update TGA Update 1. TGA restructure
More informationRegulatory Burdens Social & Economic Infrastructure Services
Productivity Commission Regulatory Burdens Social & Economic Infrastructure Services Submission by Christian Schools Australia Ltd For further discussion regarding this submission please contact: Stephen
More informationPharmacy Department. Rotational Pharmacy Technician. Information Pack
Pharmacy Department Rotational Pharmacy Technician Information Pack 1 Contents 1. Chelsea and Westminster Healthcare NHS Foundation Trust 3 2. The Pharmacy 4 3. Services 4 3.1. Clinical Services 4 3.2.
More informationSupplementary Budget Estimates Opening statement to the Economics Committee Rod Sims, ACCC Chairman October 2014
Supplementary Budget Estimates Opening statement to the Economics Committee Rod Sims, ACCC Chairman October 2014 The ACCC has recently taken the lead in a significant product safety issue potentially affecting
More informationProfessional Standards and Guidance for the Sale and Supply of Medicines
Professional Standards and Guidance for the Sale and Supply of Medicines About this document The Code of Ethics sets out seven principles of ethical practice that you must follow as a pharmacist or pharmacy
More informationMID CHESHIRE HOSPITALS NHS FOUNDATION TRUST PHARMACEUTICAL SERVICES JOB DESCRIPTION. 75% Top Band 4 2 nd year Pharmacy Department, Leighton Hospital
MID CHESHIRE HOSPITALS NHS FOUNDATION TRUST PHARMACEUTICAL SERVICES JOB DESCRIPTION POST: BAND: LOCATION: RESPONSIBLE TO: MANAGED BY: TRAINEE PHARMACY TECHNICIAN 70% Top Band 4 1 st year 75% Top Band 4
More informationGlobal Drug Development: Keeping Australia Competitive
: Keeping Australia Competitive Mitch Kirkman, Manager Process, Training & Quality International Clinical Research Operations & Oncology General Monitoring Organisation 07/08 April 2011 Keeping Australia
More information2014, That Was The Year That Was Greg Baran, RPh, MA, FMPA Baran Consulting LLC
2014, That Was The Year That Was Greg Baran, RPh, MA, FMPA Baran Consulting LLC Objectives 1. Review the changes to the pharmacy practice act related to sterile compounding. 2. Understand the role of the
More informationCompetency-Based Educational College Outcomes:
Competency-Based Educational College Outcomes: The Competency-Based Educational College Outcomes were approved by the College of Pharmacy faculty in January, 2008. These outcomes were derived from the
More informationCHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE)
CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) Section 61-03-02-01 Definitions 61-03-02-02 Absence of Provider or Consulting Pharmacist
More informationFrequently Asked Questions (FAQs) Treatment Authorization Request (TAR) Restriction on Antipsychotic Medications for the 0-17 Population
Frequently Asked Questions (FAQs) Treatment Authorization Request (TAR) Restriction on Antipsychotic Medications for the 0-17 Population Prescriber FAQs Update January 22, 2015 1. What information is needed
More informationRelease: 1. HLTPH301C Undertake pharmacy technician duties
Release: 1 HLTPH301C Undertake pharmacy technician duties HLTPH301C Undertake pharmacy technician duties Modification History Not Applicable Unit Descriptor Descriptor This unit of competency describes
More informationBuying a Pharmacy CHECKLIST
Buying a Pharmacy CHECKLIST Do you know where to find advice and support? q PHARMACY GUILD MEMBERSHIP Don t forget to apply for Guild Membership. For information on the many benefits of Guild Membership
More informationFor us, cancer is personal. From Diagnosis: Taking the next step
For us, cancer is personal From Diagnosis: Taking the next step Contents Introduction.... 2 About Icon Cancer Care.... 3 The next step, and beyond.... 4 What can I expect at my next visit?... 4 What should
More informationOverview of Drug Pricing for Public Programs
Overview of Drug Pricing for Public Programs 1 J U L I E C R O S S, I N D E P E N D E N T C O N S U L T A N T A N N E D O N N E L L Y, P R O J E C T I N F O R M A N D F A I R P R I C I N G C O A L I T
More informationALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS
ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS 610-X-5-.01 610-X-5-.02 610-X-5-.03 610-X-5-.04 610-X-5-.05 610-X-5-.06 610-X-5-.07
More informationOur Post Arrival Services include:
Study Vision (ABN 42 067 258 315) A business of Consteam (Australia) Asia Pacific Pty Ltd PO Box 63, Rosebery NSW 2018 Phone: +61 2 9669 5225 Fax: +61 2 9669 5943 Mobile: +61 410 691 761 Email: info@studyvision.com.au
More informationSafetyFirst Alert. Errors in Transcribing and Administering Medications
SafetyFirst Alert Massachusetts Coalition for the Prevention of Medical Errors January 2001 This issue of Safety First Alert is a publication of the Massachusetts Coalition for the Prevention of Medical
More informationThis document is a summary of the Bupa Australia Pty Ltd Fund Rules. You can access the full version of the Fund Rules (which includes product
This document is a summary of the Bupa Australia Pty Ltd Fund Rules. You can access the full version of the Fund Rules (which includes product information) here. You can also access information about your
More informationPosition Paper. May 2010. Crunch Time. for residential aged care funding. Working for a fair, just and sustainable society
Position Paper May 2010 Crunch Time for residential aged care funding Working for a fair, just and sustainable society Contents Defining residential aged care 3 The challenges 6 Impacts for older people
More informationMedicinal Cannabis in Queensland. It s Past Midnight in the Garden of Good and Evil!
Medicinal Cannabis in Queensland It s Past Midnight in the Garden of Good and Evil! Contact Dr Sue Ballantyne, Director, Medicines Regulation And Quality (MRQ) MRQ@health.qld.gov.au Greg Perry or Will
More informationCHEMIST WAREHOUSE SUBMISSION TO THE COMPETITION POLICY REVIEW
CHEMIST WAREHOUSE SUBMISSION TO THE COMPETITION POLICY REVIEW MAY 2014 Table of contents 1. Introduction... 3 2. Outlet location decision-making... 3 3. Discounting... 4 4. The true cost of regulation...
More informationDraft guidance for registered pharmacies providing internet and distance sale, supply or service provision
Draft guidance for registered pharmacies providing internet and distance sale, supply or service provision September 2014 1 The General Pharmaceutical Council is the regulator for pharmacists, pharmacy
More informationAccreditation of a Dispensing and Pharmacy Assistant programme, Boots UK
Accreditation of a Dispensing and Pharmacy Assistant programme, Boots UK Report of an accreditation event, 19 November 2010 Introduction The General Pharmaceutical Council (GPhC) is the statutory regulator
More informationJohn Keel, CPA State Auditor. An Audit Report on Inspections of Compounding Pharmacies at the Board of Pharmacy. August 2015 Report No.
John Keel, CPA State Auditor An Audit Report on Inspections of Compounding Pharmacies at the Board of Pharmacy Report No. 15-039 An Audit Report on Inspections of Compounding Pharmacies at the Board of
More informationJOB TITLE: Trainee Pharmacy Technician
JOB TITLE: Trainee Pharmacy Technician 1. PURPOSE OF POSITION This position is responsible for helping to provide a customer focused pharmacy service using best practice guidelines to achieve optimal outcomes.
More informationTAUNTON & SOMERSET NHS FOUNDATION TRUST Department of Pharmacy Clinical Support Division. Job description
TAUNTON & SOMERSET NHS FOUNDATION TRUST Department of Pharmacy Clinical Support Division Job description JOB TITLE: GRADE: PLACE OF WORK: HOURS: RESPONSIBLE TO: ACCOUNTABLE TO: Pre-Registration - PHARMACY
More informationAustralia-wide accreditation of programs for the professional preparation of teachers. A consultation paper
Australia-wide accreditation of programs for the professional preparation of teachers A consultation paper was established as the national body for the teaching profession with funding provided by the
More informationALPHABETICAL INDEX. HIC > Annual Report 2002 03 197
ALPHABETICAL INDEX 1999 General Practitioner Memorandum of Understanding, 14, 102 30% Health Insurance Rebate, 4, 16, 107 109 360 degree feedback process, 44 80/20 rule, 65 A abbreviations and glossary,
More informationSpecialty Pharmacy? Disclosure. Objectives Technician
Disclosure What s so SPECIAL about? I have no actual or potential conflict of interest in relation to this program/presentation. Michael DeCoske, PharmD, BCPS Associate Chief Pharmacy Officer Duke University
More informationHealth Canada Manufacturing and Compounding Drug Products in Canada: A Policy Framework Guidelines for P.E.I. Community and Hospital Pharmacists
Health Canada Manufacturing and Compounding Drug Products in Canada: A Policy Framework Guidelines for P.E.I. Community and Hospital Pharmacists October 2001 In response to pharmacists questions about
More informationLocal Enhanced Service Specification for the Supply of Pharmaceutical Services to Care Homes through Community Pharmacy
Local Enhanced Service Specification for the Supply of Pharmaceutical Services to Care Homes through Community Pharmacy Contents: 1. Introduction and purpose 2. Period of Service 3. Aim of the Service
More informationPHARMACEUTICAL SOCIETY OF SINGAPORE (PSS) CERTIFIED PHARMACY TECHNICIAN COURSE WSQ ADVANCED CERTIFICATE IN HEALTHCARE SUPPORT (PHARMACY SUPPORT)
AC ANNEX 1 & 2 PHARMACEUTICAL SOCIETY OF SINGAPORE (PSS) CERTIFIED PHARMACY TECHNICIAN COURSE WSQ ADVANCED CERTIFICATE IN HEALTHCARE SUPPORT (PHARMACY SUPPORT) 29th CPTC intake 12/01/16 to 17/11/16 (updated
More informationSWC Training Health Courses 2015 Course Guide
SWC Training Health s 2015 Guide Delivering qualified training to today s health industry SWC's Head Office Level 5 (East Tower) 608 St Kilda Road Melbourne Vic 3004 Australia Phone: 61 3 9510 5030 Fax:
More informationBiologics Biosimilars
Biologics Biosimilars Q u e st i o n s Po l i c y S a fe t y What are biosimilars? Biosimilars are sometimes incorrectly and inappropriately called generic versions of original biological medicines. But
More informationGUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS
GUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS Prepared by Ad Hoc Committee on Nuclear Pharmacy Technicians Nuclear Pharmacy Section Academy of Pharmacy Practice and Management American Pharmaceutical
More informationInhaler Technique Check
Protocol October 2015 Version 1.3 Table of Contents Service Information... 2 Service objective... 2 Clinical service overview... 2 Documentation... 3 Staff Roles... 3 Facilities to support the program...
More informationCONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION
CONNECTICUT Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION (d) General Conditions. (6) All medications shall be administered only by licensed
More informationNational Certificate in Pharmacy (Technician) (Level 5) with strands in Community, and Hospital Level 5
NZQF NQ Ref 0423 Version 7 Page 1 of 8 National Certificate in Pharmacy (Technician) (Level 5) with strands in Community, and Hospital Level 5 Credits 131 or 139 This qualification has been reviewed. The
More informationFIP Education Initiatives (FIPEd)
FIP Education Initiatives (FIPEd) Henri R. Manasse Jr PhD,ScD, FFIP FIPEd Steering Committee Chair And Professional Secretary, FIP ACPE International Commission 8 May 2012 FIP Education Initiatives (FIPEd)
More information- 1 - First Time Pharmacy Managers (Revised 02/02/2011)
State of Connecticut Department of Consumer Protection Commission of Pharmacy 165 Capitol Avenue, Room 147 Hartford, CT 06106 - Telephone: 860-713-6070 ALL FIRST-TIME PHARMACY MANAGERS ARE REQUIRED TO
More information